GO:0140795 histone H3R2 arginine deiminase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140795 describes the enzymatic activity that converts histone H3 arginine at position 2 (H3R2) into citrulline, releasing ammonium, a post-translational modification known as H3R2 citrullination.
• This activity is catalyzed by peptidylarginine deiminase (PADI) enzymes, with PADI1 shown to be essential for early embryo development through histone citrullination.
• H3R2 citrullination is dynamically regulated during preimplantation development, suggesting a role in epigenetic reprogramming.
• Programmable CRISPR/dCas9-based epigenetic editing systems can now target histone citrullination to specific loci, enabling precise transcription regulation.
• Dysregulation of histone citrullination has been implicated in cancer, autoimmune diseases, and developmental disorders, making it a potential therapeutic target.
• Studying GO:0140795 requires a combination of enzymatic assays, chromatin immunoprecipitation, and CRISPR-based editing to dissect its function in development and disease.
Description
Histone H3R2 arginine deiminase activity (GO:0140795) is a molecular function that catalyzes the conversion of arginine at position 2 of histone H3 to citrulline, a process known as citrullination. This modification is part of the broader family of peptidylarginine deiminase (PADI) activities, which play critical roles in epigenetic regulation by altering histone charge and interactions with chromatin-associated proteins. The reaction consumes water and releases ammonium, and it is distinct from other histone modifications because it neutralizes the positive charge of arginine, potentially affecting chromatin structure and gene expression. Researchers are increasingly interested in GO:0140795 because it links metabolic and enzymatic processes to developmental programming and disease states. Understanding this activity at the molecular level can reveal how cells control gene expression during early embryogenesis and how its misregulation contributes to pathologies such as cancer and autoimmunity. Recent advances in CRISPR-based epigenetic editing have enabled locus-specific induction of histone citrullination, providing new tools to study this modification in vivo.
histone H3R2 arginine deiminase activity At A Glance
| GO ID | GO:0140795 |
|---|---|
| GO term | histone H3R2 arginine deiminase activity |
| Ontology | molecular_function |
| Synonym | H3-R2 citrullination; histone-arginine deiminase activity (H3-R2 specific); histone H3-R2 arginine deiminase activity |
| Definition | Catalysis of the reaction: H2O + histone H3 L-arginyl (position 2) = histone H3 L-citrullyl (position 2) + NH4+, resulting in histone H3 citrullination at position 2. |
| Major function | Post-translational modification of histone H3 at arginine 2, converting it to citrulline, which can alter chromatin structure and gene expression. |
| Enzyme family | Peptidylarginine deiminases (PADIs), particularly PADI1, PADI2, PADI3, PADI4. |
| Substrate | Histone H3 with arginine at position 2. |
| Reaction products | Citrullinated histone H3 at position 2 and ammonium. |
| Cellular context | Nucleus, chromatin. |
What Is GO:0140795?
GO:0140795 is defined as the catalysis of the reaction: H2O + histone H3 L-arginyl (position 2) = histone H3 L-citrullyl (position 2) + NH4+, resulting in histone H3 citrullination at position 2. In simpler terms, it is the enzyme activity that removes an imine group from the arginine residue at the second position of histone H3, converting it to citrulline and releasing ammonium. This activity is specific to histone H3 arginine 2 and is mediated by peptidylarginine deiminase enzymes, particularly PADI1, PADI2, PADI3, and PADI4, though the exact isoform specificity may vary by context.
Why Is histone H3R2 arginine deiminase activity Important in Cell Biology?
Histone H3R2 citrullination is a key epigenetic modification that can influence gene expression by disrupting histone-DNA and histone-protein interactions. It is essential for early embryo development, as PADI1-catalyzed histone citrullination is required for proper preimplantation development. Dysregulation of this activity has been linked to cancer, autoimmune diseases, and developmental disorders, making it a promising target for therapeutic intervention. The recent development of CRISPR/dCas9-based epigenetic editing tools allows researchers to induce locus-specific histone citrullination, opening new avenues for studying its function in precise genomic contexts.
• Regulates chromatin structure and gene expression through charge neutralization of histone H3 arginine 2.
• Essential for early embryo development and preimplantation programming.
• Implicated in cancer progression and metastasis through altered epigenetic landscapes.
• Associated with autoimmune diseases where citrullination is a hallmark.
• Provides a mechanism for rapid and reversible epigenetic regulation.
• Enables locus-specific epigenetic editing via CRISPR/dCas9 systems.
• Potential biomarker for developmental disorders and cancer diagnostics.
• Target for small-molecule inhibitors of PADI enzymes in inflammatory diseases.
• Facilitates studies of histone code crosstalk and combinatorial modifications.
• Offers a tool for synthetic biology to control gene expression.
What Happens During histone H3R2 arginine deiminase activity?
Substrate Recognition and Binding
In simple terms: The enzyme finds and binds to histone H3 at the arginine 2 position.
The first step in histone H3R2 arginine deiminase activity involves the specific recognition of histone H3 by peptidylarginine deiminase (PADI) enzymes. PADI enzymes contain a catalytic domain that binds to the target arginine residue, with specificity for arginine 2 of histone H3. This binding is influenced by the local chromatin environment and post-translational modifications on neighboring residues, which can modulate enzyme accessibility. In early embryos, PADI1 is highly expressed and localizes to the nucleus, where it interacts with chromatin to catalyze H3R2 citrullination.
Catalytic Conversion of Arginine to Citrulline
In simple terms: The enzyme chemically modifies arginine into citrulline, releasing ammonia.
Once bound, the PADI enzyme catalyzes the hydrolysis of the guanidinium group of arginine, converting it to a citrulline residue and releasing ammonium (NH4+). This reaction consumes water and is calcium-dependent for most PADI isoforms. The conversion neutralizes the positive charge of arginine, which can disrupt histone-DNA interactions and alter chromatin compaction. This modification is irreversible under physiological conditions, distinguishing it from other reversible histone modifications.
Chromatin Remodeling and Transcriptional Consequences
In simple terms: The modification changes how DNA is packaged, affecting gene activity.
Citrullination of H3R2 leads to changes in chromatin structure, often resulting in a more open or accessible chromatin state that can either activate or repress transcription depending on the genomic context. This modification can also affect the recruitment of chromatin-modifying enzymes and transcription factors, thereby influencing gene expression programs. In preimplantation embryos, dynamic H3R2 citrullination is associated with zygotic genome activation and developmental transitions.
Regulation and Reversibility
In simple terms: The process is controlled by enzyme levels and calcium signals.
Histone H3R2 arginine deiminase activity is regulated at multiple levels, including PADI enzyme expression, subcellular localization, and calcium availability. PADI enzymes require calcium for activity, and fluctuations in intracellular calcium can modulate their function. Unlike some histone modifications, citrullination is not known to be directly reversed by a specific eraser enzyme, but the modification can be diluted through cell division or replaced by histone turnover. Recent CRISPR/dCas9-based systems have been developed to artificially induce H3R2 citrullination at specific loci, providing a means to study its regulatory effects.
Key Genes Involved in GO:0140795 histone H3R2 arginine deiminase activity
The following genes and proteins are directly involved in or regulate histone H3R2 arginine deiminase activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PADI1 | Catalyzes histone H3R2 citrullination; essential for early embryo development | Knockout studies show developmental arrest; potential target for fertility research |
| PADI2 | Peptidylarginine deiminase that can citrullinate histones | Implicated in cancer and autoimmune diseases; may compensate for PADI1 loss |
| PADI3 | Peptidylarginine deiminase with histone citrullination activity | Expressed in hair follicles and epidermis; role in skin disorders |
| PADI4 | Catalyzes histone citrullination, including H3R2 | Well-studied in rheumatoid arthritis and cancer; target for inhibitors |
| H3-2A | Histone H3 variant providing substrate for citrullination | Mutations at R2 affect chromatin dynamics |
| H3-3A | Histone H3 variant substrate | Relevance in developmental gene regulation |
| H3-3B | Histone H3 variant substrate | Potential role in zygotic genome activation |
| H3C1 | Histone H3 cluster gene | Source of histone H3 for modification |
| H3C2 | Histone H3 cluster gene | Contributes to histone pool |
| H3C3 | Histone H3 cluster gene | Substrate for PADI enzymes |
| H3C4 | Histone H3 cluster gene | Involved in chromatin structure |
| H3C6 | Histone H3 cluster gene | Potential substrate in early embryos |
| H3C7 | Histone H3 cluster gene | Expressed in various tissues |
| H3C8 | Histone H3 cluster gene | Histone supply for modification |
| H3C10 | Histone H3 cluster gene | Contributes to histone H3 pool |
| H3C11 | Histone H3 cluster gene | Substrate for citrullination |
| H3C12 | Histone H3 cluster gene | Involved in chromatin dynamics |
| H3C13 | Histone H3 cluster gene | Potential role in development |
| H3C14 | Histone H3 cluster gene | Histone variant for modification |
| H3C15 | Histone H3 cluster gene | Substrate in epigenetic regulation |
How Is histone H3R2 arginine deiminase activity Regulated?
Histone H3R2 arginine deiminase activity is primarily regulated by the expression and activity of PADI enzymes, which are calcium-dependent. PADI1 expression is tightly controlled during early embryo development, with peaks coinciding with zygotic genome activation. Calcium signaling pathways can rapidly modulate PADI activity, linking extracellular signals to chromatin modifications. Additionally, the local chromatin environment, including other histone modifications and chromatin remodelers, can influence the accessibility of H3R2 to PADI enzymes. Recent studies have employed CRISPR/dCas9-based epigenetic editing to recruit PADI enzymes to specific loci, demonstrating that targeting can overcome some regulatory constraints and induce localized citrullination.
histone H3R2 arginine deiminase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PADI1 | Early embryo developmental arrest; infertility | Padi1 knockout mouse; CRISPR KO in embryos |
| PADI4 | Rheumatoid arthritis; cancer | Padi4 knockout mice; point mutation of catalytic residue |
| PADI2 | Cancer; multiple sclerosis | Overexpression in cell lines; KO in cancer models |
| H3-2A | Developmental disorders due to histone mutations | Knock-in of H3R2 mutants in stem cells |
| PADI3 | Skin disorders; hair follicle defects | Conditional KO in epidermis |
Histone H3R2 Citrullination in Cancer
Dysregulated histone citrullination has been observed in various cancers, where it can alter gene expression programs that promote proliferation, invasion, and metastasis. PADI enzymes, including PADI1 and PADI4, are often overexpressed in tumors, and their citrullination of histones can lead to changes in chromatin structure that favor oncogenic transcription. Targeting PADI activity with small-molecule inhibitors is being explored as a therapeutic strategy in cancers dependent on citrullination.
Role in Autoimmune Diseases
Citrullination is a hallmark of autoimmune diseases such as rheumatoid arthritis, where citrullinated proteins are targeted by autoantibodies. While much focus has been on non-histone citrullination, histone H3R2 citrullination may contribute to the generation of neo-epitopes and immune dysregulation. PADI4 inhibitors are in clinical trials for rheumatoid arthritis, highlighting the therapeutic potential of targeting this activity.
Developmental Disorders and Infertility
PADI1-catalyzed histone citrullination is essential for early embryo development, and its loss leads to developmental arrest in animal models. Abnormal H3R2 citrullination patterns have been associated with implantation failure and infertility. Understanding the regulation of this modification could provide insights into reproductive disorders and potential interventions.
From histone H3R2 arginine deiminase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is PADI1 required for early embryo development? | Padi1 knockout mouse or CRISPR KO in zygotes |
| Does H3R2 citrullination affect chromatin accessibility? | Point mutation of H3R2 to citrulline mimic (R2Cit) knock-in |
| Can locus-specific citrullination regulate transcription? | CRISPR/dCas9-PADI1 fusion targeted to promoter |
| What is the role of PADI4 in cancer cell proliferation? | PADI4 overexpression and knockout in cancer cell lines |
| How does calcium signaling regulate PADI activity? | Calcium chelators and live-cell imaging in embryos |
| Can PADI inhibitors reverse autoimmune phenotypes? | PADI4 point mutation (catalytic dead) knock-in mice |
How to Study the histone H3R2 arginine deiminase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro PADI activity assay | Enzymatic conversion of H3R2 to citrulline | Screening inhibitors; enzyme kinetics |
| ChIP-seq with anti-citrulline H3R2 | Genomic localization of H3R2 citrullination | Mapping modification sites in development |
| CRISPR/dCas9-PADI1 | Locus-specific induction of citrullination | Studying causal effects on transcription |
| Mass spectrometry | Quantification of citrullinated H3R2 | Validating antibody specificity; proteomics |
| RNA-seq | Transcriptional changes upon citrullination | Correlating modification with gene expression |
| Immunofluorescence | Subcellular localization of PADI enzymes and citrullinated H3 | Visualizing dynamics in embryos |
| Western blot | Protein levels of PADI enzymes and citrullinated H3 | Assessing expression changes |
| Calcium imaging | Intracellular calcium fluctuations | Linking signaling to PADI activation |
Enzymatic Assays for PADI Activity
In vitro enzymatic assays using recombinant PADI enzymes and histone H3 peptides can directly measure H3R2 citrullination. These assays typically use mass spectrometry or colorimetric detection of citrulline to quantify activity. Such methods are essential for screening inhibitors and understanding enzyme kinetics.
Chromatin Immunoprecipitation and Sequencing
ChIP-seq with antibodies specific to citrullinated H3R2 can map the genomic distribution of this modification. This approach has been used to identify loci where H3R2 citrullination occurs during development and in disease states. Combining ChIP-seq with RNA-seq allows correlation of citrullination with gene expression changes.
CRISPR-Based Epigenetic Editing
The development of CRISPR/dCas9 systems fused to PADI enzymes enables locus-specific induction of H3R2 citrullination. This technology allows researchers to study the causal effects of citrullination at defined genomic regions without global enzyme activation. Such tools are invaluable for dissecting the function of this modification in gene regulation.
Proteomics and Mass Spectrometry
Mass spectrometry-based proteomics can identify and quantify citrullinated histone H3 at R2 in complex biological samples. This method provides site-specific information and can reveal crosstalk with other histone modifications. It is particularly useful for validating findings from antibody-based assays.
How CRISPR Can Be Used to Study GO:0140795 histone H3R2 arginine deiminase activity
Knockout
CRISPR knockout of PADI1 or other PADI genes can abolish histone H3R2 citrullination, leading to developmental defects in model organisms. Knockout cell lines are valuable for studying the loss-of-function phenotypes and identifying compensatory mechanisms. For example, Padi1 knockout mice exhibit early embryonic lethality, underscoring the essential role of this activity.
Point Mutation
Introducing point mutations in the catalytic domain of PADI enzymes (e.g., cysteine to alanine) can generate catalytically dead variants that serve as negative controls. Similarly, mutating histone H3 at arginine 2 to citrulline mimics (R2Cit) or to non-modifiable residues (R2A) can dissect the specific contribution of H3R2 citrullination to chromatin function. These models are crucial for distinguishing enzymatic activity from scaffolding functions.
Knock-in
Knock-in of tagged PADI enzymes (e.g., GFP or HA) allows for live-cell imaging and chromatin immunoprecipitation to study their dynamics and interactions. Knock-in of histone H3 variants with R2 mutations can reveal the importance of this residue in development and disease. CRISPR-mediated knock-in in zygotes has been used to create mouse models with altered citrullination patterns.
Overexpression
Overexpression of PADI enzymes in cell lines or transgenic organisms can lead to hypercitrullination of histones, mimicking disease states such as cancer or autoimmunity. This approach helps identify downstream effects and potential therapeutic targets. Inducible overexpression systems allow temporal control of citrullination induction.
How EDITGENE Supports histone H3R2 arginine deiminase activity Research
Researchers studying histone H3R2 arginine deiminase activity-related genes often need to determine whether a candidate gene is causally involved in developmental processes, disease progression, or epigenetic regulation. EDITGENE provides a comprehensive suite of CRISPR-based services to facilitate these investigations, from generating knockout models to precise point mutations and locus-specific epigenetic editing.
Contact EDITGENE today to design your custom CRISPR model for histone H3R2 arginine deiminase activity research.
Frequently Asked Questions About histone H3R2 arginine deiminase activity
What is histone H3R2 arginine deiminase activity?
It is the enzymatic activity that converts arginine at position 2 of histone H3 to citrulline, a post-translational modification involved in chromatin regulation and development.
What genes are involved in histone H3R2 arginine deiminase activity?
The main genes are PADI1, PADI2, PADI3, and PADI4, which encode peptidylarginine deiminase enzymes that catalyze this reaction.
What is the GO ID for histone H3R2 arginine deiminase activity?
The Gene Ontology ID is GO:0140795.
How does histone H3R2 citrullination affect gene expression?
It neutralizes the positive charge of arginine, altering chromatin structure and influencing transcription factor binding, which can activate or repress genes.
Is histone H3R2 citrullination reversible?
Unlike some histone modifications, citrullination is not known to be directly reversed by a specific enzyme; it is thought to be diluted through cell division or histone turnover.
What diseases are associated with histone H3R2 citrullination?
It has been linked to cancer, autoimmune diseases like rheumatoid arthritis, and developmental disorders including infertility.
How can I study histone H3R2 arginine deiminase activity in the lab?
Common methods include in vitro enzymatic assays, ChIP-seq with anti-citrulline antibodies, mass spectrometry, and CRISPR-based epigenetic editing.
What is the role of PADI1 in early embryo development?
PADI1-catalyzed histone citrullination is essential for preimplantation development; its knockout leads to developmental arrest.
Can CRISPR be used to edit histone H3R2 citrullination?
Yes, CRISPR/dCas9 systems fused to PADI enzymes can induce locus-specific citrullination, enabling precise transcription regulation.
What are the research tools available for studying GO:0140795?
Tools include knockout and knock-in cell models, point mutants, overexpression systems, and CRISPR library screening, available from EDITGENE.
Conclusion
Histone H3R2 arginine deiminase activity (GO:0140795) is a critical epigenetic modification that regulates chromatin structure and gene expression, with essential roles in early development and implications in cancer and autoimmune diseases. Understanding its mechanism and regulation provides insights into fundamental biology and potential therapeutic targets. With advanced CRISPR-based tools and services from EDITGENE, researchers can now dissect the precise functions of this modification in health and disease.
References
- 1. Zhang X et al.. 2016. Peptidylarginine deiminase 1-catalyzed histone citrullination is essential for early embryo development.. Sci Rep 6:38727 PMID: 27929094
- 2. Zhang X et al.. 2024. A programmable CRISPR/dCas9-based epigenetic editing system enabling loci-targeted histone citrullination and precise transcription regulation.. J Genet Genomics 51(12):1485-1493 PMID: 38849111
- 3. Kan R et al.. 2012. Potential role for PADI-mediated histone citrullination in preimplantation development.. BMC Dev Biol 12:19 PMID: 22712504
